IMMUNOMEDICS
Summary
Immunomedics is a pharmaceutical company focusing on the development of antibody-drug conjugates for the treatment of cancer.
Deals Overview
Total Deals2
Valued Deals2
Total Value£16,780M
Avg. Deal Size£8,390M
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
